Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 12, 2026

SPS Commerce Reports Fourth Quarter and Fiscal Year 2025 Financial Results

View original at finance.yahoo.com
SPS Commerce Reports Fourth Quarter and Fiscal Year 2025 Financial Results SPS Commerce, Inc…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Recently launched agentic capabilities competitively position SPS to deliver more meaningful and scalable AI enhancements

    80% confidence

  • The 100th consecutive quarter of revenue growth speaks to the durability of SPS Commerce's business model and disciplined financial strategy

    80% confidence

  • Kim Nelson has been a steady, trusted leader through defining chapters including IPO and evolution into global organization achieving 100 consecutive quarters of growth

    80% confidence

  • Joe will build on the strong foundation Kim created and help guide SPS through next chapter of growth

    80% confidence

  • SPS Commerce remains focused on driving balanced, profitable growth and delivering long-term value

    80% confidence

  • SPS Commerce's sustained and profitable growth and ongoing network expansion demonstrate success in delivering products and services that retailers and suppliers depend on

    80% confidence

  • Fiscal year 2026 revenue expected to be $798.5M to $806.9M, representing 6-7% growth over 2025

    80% confidence

  • Fiscal year 2026 Adjusted EBITDA expected to be $261.0M to $265.5M, representing 13-15% growth over 2025

    80% confidence

  • Joseph Del Preto brings deep experience leading finance organizations at scale and leadership style that aligns with SPS Commerce values

    80% confidence

  • Q1 2026 revenue expected to be $191.6M to $193.6M, representing 6-7% year-over-year growth

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com